In this presentation, the target audience includes individuals interested in Translational Molecular Imaging in Neurodegenerative Diseases. Preclinical and Clinical studies will be discussed. The objectives of this presentation are to review the current state of molecular MRI in neurodegenerative diseases and to review some of the current challenges.